Onyema Greg Chido-Amajuoyi

Onyema Greg Chido-Amajuoyi

Auto-generated profile, based on publicly available information

Onyema Greg Chido-Amajuoyi

The University of Texas MD Anderson Cancer Center

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2020 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Open access
OCOnyema Greg Chido-Amajuoyi
Onyema Greg Chido-Amajuoyi
IJInimfon Jackson
Inimfon Jackson
RYRobert Yu
Robert Yu
SSSanjay Shete
Sanjay Shete
Programs aimed at boosting human papillomavirus (HPV)-related awareness are considered one of the most effective strategies for increasing vaccination uptake and eliminating HPV-associated cancers. Several US states have made strong commitments to this effort through legislation and dedicated funds. However, it is not known if these efforts have resulted in population-level increments in HPV awareness overtime. Using the Health Information National Trends Survey data, we examined the awareness of HPV and HPV vaccine in the US, between 2008 and 2018. Prevalence estimates and confidence intervals were calculated for HPV and HPV vaccine awareness. Further, we assessed awareness after stratifying by key sociodemographic characteristics. Overall, the awareness of HPV and HPV vaccine declined over time. The lowest awareness was among racial minorities, rural residents, male respondents, those aged 65 years and older, as well as those with the lowest educational and socioeconomic standing. Between 2013 and 2018, the awareness of HPV and HPV vaccine declined by almost 10% among males, those with a high school level of education or lower, and those who earned less than USD 35,000 per annum. In 2018, the awareness of HPV and HPV vaccine was highest among non-Hispanic whites (65.8% and 66.5%) and female adults (70.5% and 71.4%); however, these figures represented declines of about 5% from rates observed in 2008. Amidst a background of sub-optimal HPV vaccination uptake and a growing incidence of HPV-associated cancers in the US, HPV-related awareness within the general US population has declined over time. This calls for stricter enforcement of legislation aimed at boosting HPV awareness, as well as frequent evaluation of government-funded HPV awareness programs.

10 August 2017 in BMJ Global Health
Verified
Journal Article
Open access
PDF file
OCOnyema G Chido-Amajuoyi
Onyema G Chido-Amajuoyi
DMDale S Mantey
Dale S Mantey
SCStephanie L Clendennen
Stephanie L Clendennen
APAdriana Pérez
Adriana Pérez
Background This study investigates the association between exposure to tobacco advertising, promotion and sponsorship (TAPS) and cigarette use behaviours among adolescents in five Nigerian regions. This is imperative given a 2015 WHO report on the global tobacco epidemic, revealing Nigeria has not met any of the MPOWER TAPS ban indicators instituted since 2008. Methods Secondary data analysis of the 2008 Global Youth Tobacco Survey for Nigeria. Participants were 1399 adolescents, representative of 5 Nigerian regions. Weighted multivariable logistic regression models were used to assess the relationship between TAPS exposure and (1) past 30-day (current) cigarette use, (2) ever cigarette use and (3) susceptibility to use cigarettes among never cigarette users. Sensitivity analysis via complete case analysis and multiple imputation were conducted. Results Ninety-five per cent of Nigerian adolescents reported exposure to TAPS. Among adolescents who had never smoked, 15% were susceptible to use cigarettes. Cumulative TAPS exposure was significantly associated with both an increased odds of current cigarette use (AOR: 1.73; 95% CI 1.09 to2.99) and ever cigarette use (AOR: 1.29; 95% CI 1.15 to1.45); as well as increased susceptibility to cigarette smoking (AOR: 1.18; 95% CI 1.03 to 1.34), among non-smokers. Conclusion Given study results, the emergence of new tobacco products and novel platforms for TAPS globally, implementation of existing policies and enhancement of efforts to attain comprehensive bans on all forms of direct and indirect TAPS in line with article 13 of the WHO Framework Convention on Tobacco Control are needed to reduce TAPS exposure and curtail tobacco use in Nigeria.

1 November 2018 in Vaccine
Verified
Journal Article
Closed access
OCOnyema Greg Chido-Amajuoyi
Onyema Greg Chido-Amajuoyi
CWChizoba Barbara Wonodi
Chizoba Barbara Wonodi
Dale ManteyDale Mantey
Dale Mantey
APAdriana Perez
Adriana Perez
AMAlfred Mcalister
Alfred Mcalister

3 May 2021 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
OCOnyema Greg Chido-Amajuoyi
Onyema Greg Chido-Amajuoyi
PFPatrick Fueta
Patrick Fueta
DMDale Mantey
Dale Mantey
The 2020 World No Tobacco Day campaign was focused on promoting measures to protect children and young people from exploitation by the tobacco industry. This comes as more than 40 million adolescents aged 13 to 15 years are reported to have already initiated tobacco use.1

26 November 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
IOIkponmwosa Osaghae
Ikponmwosa Osaghae
CDCharles Darkoh
Charles Darkoh
OCOnyema Greg Chido-Amajuoyi
Onyema Greg Chido-Amajuoyi
WCWenyaw Chan
Wenyaw Chan
PWPaige Padgett Wermuth
Paige Padgett Wermuth
SSSanjay Shete
Sanjay Shete
HPV vaccine hesitancy is a key barrier to HPV vaccination. Using a population-based survey of HCPs practicing in Texas we determined the association between formal training of HCPs and perceived self-efficacy in counseling HPV vaccine-hesitant parents and adult patients. A total of 1283 HCPs completed the survey, with 879 providing vaccination services to pediatric patients and 1018 providing vaccination services to adult patients. Among HCPs included in this study, 405 of 577 (70%) and 315 of 505 (62%) perceived they were very/completely confident in counseling HPV vaccine-hesitant parents and adult patients, respectively. Compared to HCPs who received no training, those who received formal training in HPV vaccination promotion or counseling had 2.56 (AOR: 2.56; 95% CI:1.69–3.86) and 2.84 times higher odds (AOR: 2.84; 95% CI:1.87–4.33) of perceiving that they were very/completely confident in counseling HPV vaccine-hesitant parents and adult patients, respectively. Additionally, increasing years of practice and volume of patients seen were positively associated with being very/completely confident in counseling HPV vaccine-hesitant parents and adult patients. On the other hand, nurses were less likely than physicians to be very/completely confident in counseling HPV vaccine-hesitant parents. To increase HPV vaccination uptake, HCPs should receive tailored training to improve their self-efficacy in addressing HPV vaccine-hesitancy.

26 February 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
OCOnyema Greg Chido-Amajuoyi
Onyema Greg Chido-Amajuoyi
IOIkponmwosa Osaghae
Ikponmwosa Osaghae
IAIsrael Terungwa Agaku
Israel Terungwa Agaku
BCBaojiang Chen
Baojiang Chen
Dale ManteyDale Mantey
Dale Mantey
Objectives To describe the prevalence of school-based tobacco prevention programme exposure among adolescents in low-income and middle-income countries (LMICs) and its association with psychosocial predictors of smoking. Design Analysis of pooled cross-sectional data. Setting Global Youth Tobacco Survey (GYTS), conducted in 38 LMICs. Participants This was a pooled analysis of data involving a total of 132 755 adolescent respondents to GYTS in 38 LMICs across Africa, Europe and Central/South America between 2014 and 2017. Exposure and outcome measures The primary independent variable for this study was self-reported exposure to school-based tobacco prevention programmes in the past year. Five psychosocial determinants of smoking were explored as outcomes: perceived addictiveness of nicotine, perceived harm of secondhand smoke exposure, support for restricting cigarette smoking at public indoor locations, support for restricting cigarette smoking at public outdoor areas and self-reported prediction of enjoying cigarette smoking. Multivariable logistic regression models were used to examine the relationship between exposure to school-based tobacco prevention programmes and study outcomes, controlling for sociodemographic and smoking-related characteristics of respondents. Results Overall, 59.1% of adolescents in LMICs self-reported exposure to school-based tobacco prevention programmes. The country-specific prevalence of adolescent exposure to school-based tobacco interventions ranged from 24.9% in the Comoros to 99.3% in Turkmenistan. Exposure to school-based tobacco interventions was significantly associated with greater secondhand smoke harm perceptions (adjusted OR (AOR): 1.69; 95% CI: 1.69 to 1.70), perceptions of addictiveness (AOR: 1.37; 95% CI: 1.36 to 1.37) and supporting tobacco use restrictions indoors (AOR: 1.70; 95% CI: 1.69 to 1.70) and outdoors (AOR: 1.59; 95% CI: 1.59 to 1.60). Exposure to school-based tobacco interventions was associated with lower odds of anticipating enjoying cigarette smoking (AOR: 0.76; 95% CI: 0.76 to 0.76). Conclusion Exposure to tobacco prevention programmes in schools is suboptimal in LMICs. Given the protective associations described in this study from school-based tobacco prevention programme exposure, it is imperative that national governments implement school-based programmes into ongoing tobacco control measures.